Harold H. Shlevin, Director at GALECTIN THERAPEUTICS INC (GALT), sold 56,420 shares at $6.27 ($354K) on 2025-12-12, disclosed to the SEC on 2025-12-16.
Scheduled sale ($354k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.27 | 19,793 | $124K | 35.0% |
| 2 | $6.27 | 19,793 | $124K | 35.0% |
| 3 | $6.30 | 8,417 | $53K | 15.0% |
| 4 | $6.30 | 8,417 | $53K | 15.0% |
| Total | $6.28 avg | 56,420 | $354K | 100% |
| Filing → |
| GALT | SELL | 2025-12-10 | $1.3M | — | Filing → |
| GALT | BUY | 2024-12-31 | $8K | — | Filing → |
| GALT | SELL | 2018-06-14 | $565K | — | Filing → |